Target intelligence / Profile preview

Thymosin beta pseudogene

Molecular classification: Other (Pseudogene; not protein-coding)

Overview

Thymosin beta pseudogenes are genomic sequences highly similar to the active thymosin beta genes (such as TMSB4X and TMSB10) but lack the ability to encode functional proteins. Pseudogenes are generally regarded as non-coding DNA without biological activity, though they may occasionally contribute to gene regulation or evolutionary processes. The target ENSG00000223967 does not correspond to an active therapeutic molecule, receptor, enzyme, or transporter; therefore, it does not have a role in signaling, disease, or drug action.

Other names: Thymosin beta pseudogeneTMSB4X pseudogene

Beyond the preview

Go deeper on Thymosin beta pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thymosin beta pseudogene.

Explore the full profile